SOLV Performance: -4.3% Return (12 Months)
SOLV returned -4.3% over 12 months, underperforming the S&P 500 (32.2%). Volatility: 28.5%.
| P/E Trailing | 7.16 |
| P/E Forward | 10.1 |
| 52 Week High | 86.14 USD |
| 52 Week Low | 62.49 USD |
| VRO Trend Strength ±100 | 11.54 |
| Buy Signal ±3 | -0.88 |
| Max Drawdown | 39.97% |
| Mean Drawdown | 15.34% |
Top Performer in Health Care Equipment (5/86)
| SYMBOL | 1W | 1M | 3M |
|---|---|---|---|
| VMD | 4.34% | 3.44% | 32.19% |
| PLSE | -7.55% | 9.34% | 31.32% |
| MASS | 10.46% | 6.21% | 24.04% |
| CCLD | -11.51% | 18.32% | 6.95% |
| BLLN | 12.05% | 22.66% | -1.11% |
| SOLV | -4.30% | -8.91% | -25.82% |
| SYMBOL | 6M | 12M | 5Y |
|---|---|---|---|
| BWAY | 61.00% | 184.79% | 161.69% |
| CATX | 25.94% | 142.78% | -59.16% |
| BFLY | 62.00% | 95.65% | -75.68% |
| TALK | 89.01% | 94.72% | -48.04% |
| AXGN | 83.37% | 86.46% | 54.49% |
| SOLV | -13.40% | -4.33% | -21.89% |
| SYMBOL | MCAP | 1M | 12M | 5Y | P/E | P/E fwd | PEG | EPS stab | EPS cagr |
|---|---|---|---|---|---|---|---|---|---|
| BWAY NASDAQ Brainsway |
544M | -3.16% | 185% | 162% | 75.4 | 64.5 | - | 83.9% | 20.2% |
| LMAT NASDAQ LeMaitre Vascular |
2.47B | 0.47% | 40.2% | 125% | 43.1 | 37.6 | 3.13 | 45.5% | -34.6% |
| GMED NYSE Globus Medical |
11.9B | 2.49% | 27.2% | 34.3% | 22.4 | 19.7 | 1.49 | 91.5% | 34.6% |
| IDXX NASDAQ IDEXX Laboratories |
45.3B | -5.84% | 51.7% | 14.3% | 43.5 | 39.5 | 3.96 | 77.9% | 8.48% |
| TCMD NASDAQ Tactile Systems Technology |
560M | -17.0% | 80.4% | -55.5% | 30.0 | 19.1 | 17.2 | 49.8% | 172% |
| BVS NASDAQ Bioventus |
604M | 2.67% | 6.89% | -35.7% | 27.2 | 11.9 | 1.19 | 47.0% | 61.3% |
| PEN NYSE Penumbra |
13.0B | -2.84% | 25.2% | 21.3% | 72.9 | 63.7 | 0.74 | 60.5% | -3.72% |
| TMDX NASDAQ TransMedics |
3.59B | -20.4% | 55.2% | 238% | 21.5 | 40.3 | - | 63.5% | 21.0% |
| MDT NYSE Medtronic |
111B | -4.61% | 7.24% | -17.5% | 24.2 | 14.1 | 1.50 | 20.7% | -2.92% |
| SNN NYSE Smith & Nephew SNATS |
13.7B | -5.48% | 26.6% | -5.90% | 22.5 | 12.5 | 0.66 | 0.90% | -69.0% |
Performance: SOLV vs S&P 500
| PERIOD | SOLV | S&P 500 | DIFFERENCE |
|---|---|---|---|
| 1 Month | -8.91% | -2.54% | -6.53% |
| 3 Months | -25.82% | -4.14% | -22.61% |
| 6 Months | -13.40% | -0.92% | -12.60% |
| 12 Months | -4.33% | 32.20% | -27.63% |
| 5 Years | -21.89% | 71.53% | -39.99% |
SOLV Performance FAQ
Does SOLV outperform the market?
No, SOLV underperforms the market. Over the past 12 months, SOLV returned -4.33% compared to 32.20% for the S&P 500.
What is the SOLV return over the last 12 months?
SOLV has returned -4.33% over the past 12 months, including dividends. Over 3 months the return was -25.82%, and over 5 years -21.89%.
How risky is SOLV?
SOLV has relatively low risk with a maximum drawdown of 39.97% over the past 3 years. The average drawdown is 15.34%.
SOLV vs Sectors (12m)
Sorted by outperformance. Positive = SOLV beats sector.
| SECTOR | ETF | DIFFERENCE 12M |
|---|---|---|
| Consumer Staples | XLP | -12% |
| Health Care | XLV | -15.3% |
| Real Estate | XLRE | -17.9% |
| Financials | XLF | -19.2% |
| Consumer Discretionary | XLY | -24.6% |
| Communication Services | XLC | -33.9% |
| Communication Services | XLC | -33.9% |
| Materials | XLB | -37.6% |
| Industrials | XLI | -46.2% |
| Technology | XLK | -55% |
| Energy | XLE | -63% |
SOLV vs Asset Classes (12m)
| ASSET CLASS | ETF | DIFFERENCE 12M |
|---|---|---|
| S&P 500 | SPY | -27.63% |
| Gold | GLD | -62.1% |
| Long-Term Bonds | TLT | -4.9% |